News

safe exercise level, atrial fibrillation, AF, men, women, HRS

New research reports significant differences between men and women with atrial fibrillation (AF) and the safety of intense physical activity. The study found that both moderate and vigorous levels...

cilostazol, DAPT, bridge therapy, surgery, bleeding risk, SCAI

Patients with a high-risk paclitaxel drug-eluting stent given the shorter-acting antiplatelet drug cilostazol prior to a surgical procedure safely transitioned off of dual antiplatelet therapy (...

HRS, early menopause, atrial fibrillation, Women's Health Study

A largest-of-its kind study has found that women who experience menopause at a younger age are at a decreased risk of atrial fibrillation (AF). The study followed nearly 18,000 women and revealed...

HRS, ECG, smartphones, atrial fibrillation, AF, Heart Rhythm 2015

A new, large-scale study has found adding an electrocardiogram (ECG) to the latest generation of body-worn sensors accurately detects atrial fibrillation (AF) and significantly increases awareness...

PROMETHEUS, prasugrel, clopidogrel, heart disease, bleeding, SCAI

Prasugrel (Effient) is more likely to be given to lower-risk heart disease patients undergoing percutaneous coronary intervention (PCI) compared to clopidogrel, according to a new study. Results...

A new study reports that antiplatelet drug ticagrelor (Brilinta) works faster and is more effective in blocking platelet activity in low-risk patients with acute coronary syndrome (ACS) than...

blood pressure, LDL, medication therapy, coronary plaque, SCAI

Combining statins for low-density lipoprotein (LDL) and calcium channel antagonists for blood pressure reduces harmful coronary plaque, according to a study presented at the Society of...

HRS, National Stroke Association, atrial fibrillation, AF, misperceptions, paper

A white paper published by the Heart Rhythm Society (HRS) and National Stroke Association characterizes the impact of stroke on patients with atrial fibrillation (AF) and presents common barriers...

ORBIT II, Diamondback 360, CSI, SCAI 2015, atherectomy

Cardiovascular Systems Inc. (CSI) featured two-year data from its ORBIT II study of the company’s Diamondback 360 coronary orbital atherectomy system (OAS) in a late-breaking presentation at...

heart regeneration, zebrafish, epicardium, Duke, Poss

While the human heart can’t heal itself, the zebrafish heart can easily replace cells lost by damage or disease. Now, researchers have discovered properties of a mysterious outer layer of the...

pulmonary valve replacement, congenital, re-intervention, age, PVR

A retrospective review of 633 adults and children who underwent bioprosthetic pulmonary valve replacement (PVR) for congenital heart disease between 1996 and 2014 indicated that the risk of re-...

EHRs, outcomes, ischemic stroke, ACC

Hospitals with electronic health records (EHRs) for ischemic stroke patients did not demonstrate better quality of care or clinical outcomes for those patients when compared to similar hospitals...

Medtronic, SYMPLICITY AF, PVI, renal denervation, Arctic Front, Spyral, G3

Medtronic plc announced the start of a clinical study to determine whether paroxysmal and persistent atrial fibrillation (AF) can be treated with a combination of two ablation procedures targeting...

therapeutic hypothermia, children, cardiac arrest, treatment, temperature

A large-scale, multicenter study has shown that therapeutic hypothermia does not improve survival rates or reduce brain injury in infants and children with out-of-hospital cardiac arrest more than...

Vessix Renal Denervation System, REDUCE-HTN: REINFORCE, high blood pressure

Boston Scientific Corp. is taking a new approach to evaluate the performance of the Vessix Renal Denervation System, initiating a study to isolate the effects of the therapy in patients with...

Sunshine Heart, C-Pulse, COUNTER HF, FDA, review, pause, enrollment

Sunshine Heart Inc. announced that the U.S. Food and Drug Administration (FDA) has reviewed the company’s submission regarding the pause of the COUNTER HF U.S. pivotal study. The FDA has requested...

One life-threatening complication of lung cancer surgery is the formation of blood clots in the lungs (also called pulmonary embolism, PE) or in the legs (also known as deep vein thrombosis, DVT...

The Society for Cardiovascular Angiography and Interventions (SCAI) announced the following late-breaking clinical trials to be presented at its 2015 Scientific Sessions, May 6-9 in San Diego.

Medtronic, SWIFT PRIME, REVASCAT, Solitaire, stent thrombectomy, stroke

Two global trials have found that the addition of the Solitaire device stent thrombectomy procedure to current pharmaceutical treatment significantly reduced disability in patients...

Boston Scientific, Eluvia, MAJESTIC trial, vascular stent, PAD

A key trial evaluating the Boston Scientific Eluvia drug-eluting vascular stent system met its primary endpoint, with more than 94 percent of the lesions treated for peripheral arterial disease (...